ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
The primary objective of the ASA-3C trial is to evaluate the role of aspirin and high-intensity statin therapy, respectively, in individuals with severe coronary calcification (coronary calcium score ≥400) to prevent atherosclerotic cardiovascular disease (ASCVD) events with severe coronary calcification (CAC ≥400).
Epistemonikos ID: dcf4259ca12ba0cbc7e2b0f8ab4b80d57d895df6
First added on: Dec 01, 2024